Kunal Dhamesha · Macquarie
directWhy is inpatient volume growth muted in core southern markets in Q2?
Actually, if you're looking at the quarter two, it is a quarter where we have a high volume of medical cases, particularly this, because the monsoon-related cases like dengue and stuff like that, which we had in the last year, second quarter. But I guess because of a delayed monsoon or whatever may be the reason, we did not have that influx of medical cases during the second quarter this year, especially in the southern region.
Kunal Dhamesha · Macquarie
directWhat is driving double-digit ARPOB growth and current payer mix?
Pricing-wise, we have not taken any price increases in this quarter... We are getting better realizations from insurance.... Payer mix is, you know, there is an 18% growth. ...our insurance revenues have actually grown by 18% in the same year. ...almost 43% rather, and 38% comes from self-pay. International is 20%, and we are now around 7.5% of our revenue is coming from international.
Nikhil Mathur · HDFC Mutual Fund
directIs hospital growth plateauing without expansion?
No, that's not true. ...we had a 4% volume growth. But even within the volume growth of 4%, if you look at the, mix, we had a 7% growth from surgeries. ...68%, still, you know, there is headroom for growth. We can take it to 70%, 72% next year...
Nikhil Mathur · HDFC Mutual Fund
directCan low double-digit growth be achieved without expansion?
Yes.
Nikhil Mathur · HDFC Mutual Fund
partialWhy focus expansion on metros rather than non-metros?
Well, I think we have a very calibrated expansion plan. And the cities that we have selected, it's actually the one-year strategic study, where we looked at one, the size of the market, the ability to pay. Secondly, ability for us in those institutions.
Neha Manpuria · Bank of America
directWhat is the pace of store additions and OpEx reduction for pharmacy?
Our plan to add about 500+ stores is on. ...we had INR 190 crore of operating expenses... From INR 190 crore, we are down to INR 162 crore, and I strongly believe that, you know, another INR 10 crore-INR 15 crore will further come down as we move forward.
Neha Manpuria · Bank of America
directIs the Rourkela tie-up part of expansion plan?
Well, yeah, it's not. We are not investing capital in that asset. Incidentally, it's a fully managed asset-light model that we have. ...it's something that has been developed by Steel Authority of India, and they have, you know, they have given it an operations management contract to us.
Shyam Srinivasan · Goldman Sachs
directWhy were hospital margins lower and what is the outlook?
So our margins were at 24.9%. There was 75 basis points decrease because of we have spent on acquisition of doctors, guarantee money for doctors. In fact, we put 100 new doctors into the pipeline, and this has led to an increase in cost, plus the 0.5% increase in marketing cost.
Bino Pathiparampil · Elara Capital
directWhy did Karnataka operating beds reduce?
We're doing some refurbishments in Karnataka and Chennai, so there has been a reduction. And also, the shift, I think earlier we mentioned that, you know, we are replacing some of the general wards with semi-private because of the penetration of insurance...
Bino Pathiparampil · Elara Capital
partialWhy are pharmacy and AHLL margins down YoY?
On the pharmacy, our margins have remained stable in the last two quarters... If you look at it last year, from last year to now, if you look at it, you know, we had increased the costs in the... There were higher costs in the online business, and also, and which is all starting to come off now...
Nitin Agarwal · DAM Capital
directWhat is the EBITDA margin for H1 and revenue for pharmacy?
About H2 is 5.7. H1, H1 is 5.6. We have INR 4,700 crore.
Nitin Agarwal · DAM Capital
directWhat is the EBITDA margin guidance for hospital business?
Definitely move it above 70, 72 is something that we are working on. ...we should be looking at at least a 200 basis point increase in the overall EBITDA margins.
